-
Can we improve the efficiency of early phase trials in pediatric oncology?
Esther Blanco & Darren Hargrave
Clinical Trail Perspective: Clinical Investigation
-
Can we improve the efficiency of early phase trials in pediatric oncology?
Esther Blanco & Darren Hargrave
Clinical Trail Perspective: Clinical Investigation
-
Can we improve the efficiency of early phase trials in pediatric oncology?
Esther Blanco & Darren Hargrave
Clinical Trail Perspective: Clinical Investigation
-
Can we improve the efficiency of early phase trials in pediatric oncology?
Esther Blanco & Darren Hargrave
Clinical Trail Perspective: Clinical Investigation
-
Can we improve the efficiency of early phase trials in pediatric oncology?
Esther Blanco & Darren Hargrave
Clinical Trail Perspective: Clinical Investigation
-
Can we improve the efficiency of early phase trials in pediatric oncology?
Esther Blanco & Darren Hargrave
Clinical Trail Perspective: Clinical Investigation
-
Can we improve the efficiency of early phase trials in pediatric oncology?
Esther Blanco & Darren Hargrave
Clinical Trail Perspective: Clinical Investigation
-
Can we improve the efficiency of early phase trials in pediatric oncology?
Esther Blanco & Darren Hargrave
Clinical Trail Perspective: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
CGRP antagonists for the treatment of migraine: rationale and clinical data
Lars Edvinsson, Mattias Linde
Review: Clinical Trail Outcomes: Clinical Investigation
-
CGRP antagonists for the treatment of migraine: rationale and clinical data
Lars Edvinsson, Mattias Linde
Review: Clinical Trail Outcomes: Clinical Investigation
-
CGRP antagonists for the treatment of migraine: rationale and clinical data
Lars Edvinsson, Mattias Linde
Review: Clinical Trail Outcomes: Clinical Investigation
-
CGRP antagonists for the treatment of migraine: rationale and clinical data
Lars Edvinsson, Mattias Linde
Review: Clinical Trail Outcomes: Clinical Investigation
-
CGRP antagonists for the treatment of migraine: rationale and clinical data
Lars Edvinsson, Mattias Linde
Review: Clinical Trail Outcomes: Clinical Investigation
-
CGRP antagonists for the treatment of migraine: rationale and clinical data
Lars Edvinsson, Mattias Linde
Review: Clinical Trail Outcomes: Clinical Investigation
-
CGRP antagonists for the treatment of migraine: rationale and clinical data
Lars Edvinsson, Mattias Linde
Review: Clinical Trail Outcomes: Clinical Investigation
-
CGRP antagonists for the treatment of migraine: rationale and clinical data
Lars Edvinsson, Mattias Linde
Review: Clinical Trail Outcomes: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation